# Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)

Study · id `cardio:ct-nct06157502` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06157502](<https://clinicaltrials.gov/study/NCT06157502>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06157502

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1380 participants.

## Technical summary

Registry record NCT06157502. Randomized; triple masking; primary purpose treatment. Start 2024-01-11 (actual); primary completion 2025-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1380 participants (planned count; ClinicalTrials.gov record NCT06157502, source copy `cardio:ctgov-nct06157502-2025-07-24`, retrieved 2026-10-26)
- Started: 2024-01-11 (actual) (ClinicalTrials.gov record NCT06157502, source copy `cardio:ctgov-nct06157502-2025-07-24`, retrieved 2026-10-26)
- Primary completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT06157502, source copy `cardio:ctgov-nct06157502-2025-07-24`, retrieved 2026-10-26)
- Completion: 2026-07-31 (anticipated) (ClinicalTrials.gov record NCT06157502, source copy `cardio:ctgov-nct06157502-2025-07-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06157502, source copy `cardio:ctgov-nct06157502-2025-07-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06157502-2025-07-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
- Condition: Ischemic Stroke, Acute
- Intervention (Drug): Shuxuening Injection
- Intervention (Other): Placebo
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: 995c9f73d5f01590bb93a8c581d8f50025ec2c89c57188b6d17eea5e5e155705
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
